Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


CDER’s Sequestration Strategy Aided By 400 Missing FTEs

This article was originally published in The Pink Sheet Daily

Executive Summary

FDA’s ability to avoid furloughs under sequester is not good news, OND Director John Jenkins says, but instead is a sign of severe understaffing that already existed.


Related Content

ANDA Pre-Submission Meetings Being Considered By FDA
PDUFA Communications Hurt By Sequestration As Late-Stage Meetings Begin
GDUFA Self-Identification Woes Can’t Deflate Industry, FDA Enthusiasm





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts